These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 19673859)

  • 1. Joint inference on HIV viral dynamics and immune suppression in presence of measurement errors.
    Wu L; Liu W; Hu XJ
    Biometrics; 2010 Jun; 66(2):327-35. PubMed ID: 19673859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous inference for longitudinal data with detection limits and covariates measured with errors, with application to AIDS studies.
    Wu L
    Stat Med; 2004 Jun; 23(11):1715-31. PubMed ID: 15160404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian inference on joint models of HIV dynamics for time-to-event and longitudinal data with skewness and covariate measurement errors.
    Huang Y; Dagne G; Wu L
    Stat Med; 2011 Oct; 30(24):2930-46. PubMed ID: 21805486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dynamic study of anti-HIV antibody avidity after cellular immunity restoration under antiretroviral treatment].
    Riou M; Renier G; Mattman S; Fialaire P; Loison J; Chennebault JM; Payan C
    Ann Biol Clin (Paris); 2000; 58(6):715-20. PubMed ID: 11098168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change points in the series of T4 counts prior to AIDS.
    Kiuchi AS; Hartigan JA; Holford TR; Rubinstein P; Stevens CE
    Biometrics; 1995 Mar; 51(1):236-48. PubMed ID: 7766779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A flexible B-spline model for multiple longitudinal biomarkers and survival.
    Brown ER; Ibrahim JG; DeGruttola V
    Biometrics; 2005 Mar; 61(1):64-73. PubMed ID: 15737079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Joint inference for nonlinear mixed-effects models and time to event at the presence of missing data.
    Wu L; Hu XJ; Wu H
    Biostatistics; 2008 Apr; 9(2):308-20. PubMed ID: 17728318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
    Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
    HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markov modelling of changes in HIV-specific cytotoxic T-lymphocyte responses with time in untreated HIV-1 infected patients.
    Kousignian I; Autran B; Chouquet C; Calvez V; Gomard E; Katlama C; Rivière Y; Costagliola D;
    Stat Med; 2003 May; 22(10):1675-90. PubMed ID: 12720304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dynamics of T lymphocyte subsets in HAART treated AIDS patients with successful suppression of HIV replication and different CD4 + T cell restoration].
    Qiu ZF; Li TS; Ruan GR; Han Y; Xie J; Zuo LY; Li YL; Wang AX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):386-90. PubMed ID: 16900640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A statistical model to analyse quantitative trait locus interactions for HIV dynamics from the virus and human genomes.
    Wang Z; Hou W; Wu R
    Stat Med; 2006 Feb; 25(3):495-511. PubMed ID: 16013038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein is a marker for human immunodeficiency virus disease progression.
    Lau B; Sharrett AR; Kingsley LA; Post W; Palella FJ; Visscher B; Gange SJ
    Arch Intern Med; 2006 Jan; 166(1):64-70. PubMed ID: 16401812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneously modelling censored survival data and repeatedly measured covariates: a Gibbs sampling approach.
    Faucett CL; Thomas DC
    Stat Med; 1996 Aug; 15(15):1663-85. PubMed ID: 8858789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feedback control of a biodynamical model of HIV-1.
    Brandt ME; Chen G
    IEEE Trans Biomed Eng; 2001 Jul; 48(7):754-9. PubMed ID: 11442287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AIDS pathogenesis: from models to viral dynamics in patients.
    Nowak MA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S1-5. PubMed ID: 8595501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling the short-, middle- and long-term viral load responses for comparing estimated dynamic parameters.
    Huang Y
    Biom J; 2007 Jun; 49(3):429-40. PubMed ID: 17623347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of immune suppression in AIDS: possibilities of prevention.
    Gluckman JC; Klatzmann D
    Cancer Detect Prev; 1988; 12(1-6):175-80. PubMed ID: 3052831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
    Skiest DJ; Su Z; Havlir DV; Robertson KR; Coombs RW; Cain P; Peterson T; Krambrink A; Jahed N; McMahon D; Margolis DM;
    J Infect Dis; 2007 May; 195(10):1426-36. PubMed ID: 17436222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural variation in HIV infection: Monte Carlo estimates that include CD8 effector cells.
    Heffernan JM; Wahl LM
    J Theor Biol; 2006 Nov; 243(2):191-204. PubMed ID: 16876200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal immune dysfunction in AIDS pathogenesis.
    Paiardini M; Frank I; Pandrea I; Apetrei C; Silvestri G
    AIDS Rev; 2008; 10(1):36-46. PubMed ID: 18385779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.